Cervical carcinoma in Algiers, Algeria: Human papillomavirus and lifestyle risk factors

International Journal of Cancer

Volumn 113, Issue 3, 2005, Pages 483-489

  Hammouda, Doudja ^a   Muñoz, Nubia ^b   Herrero, Rolando ^c   Arslan, Annie ^b   Bouhadef, Anissa ^d   Oublil, Malika ^a   Djedeat, Belhout ^e   Fontanière, Bernard ^f   Snijders, Peter ^g   Meijer, Chris ^g   Franceschi, Silvia ^b  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE   (Algeria)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c Inst Costarricense Invest y E   (Costa Rica)

^d CHU Alger   (Algeria)

^e Centre Pierre et Marie Curie   (Algeria)

^f CENTRE LÉON BÉRARD   (France)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cervical cancer; Education; Human papillomavirus; Parity; Sexual habits; Social class

Indexed keywords

VIRUS VACCINE;

ADULT; AFRICA; ALGERIA; ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; HYGIENE; INTRAUTERINE CONTRACEPTIVE DEVICE; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIPARA; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTITUTION; RISK FACTOR; RURAL AREA; SANITATION; SEXUAL BEHAVIOR; SEXUALITY; SPOUSE; SUPERINFECTION; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS INFECTION; VIRUS TYPING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALGERIA; CARCINOMA, ADENOSQUAMOUS; CASE-CONTROL STUDIES; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 19944396756     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20600     Document Type: Article

References (20)

1. Parkin DM, Ferlay J, Hamdi-Chérif M, Sitas F, Thomas JO, Wabinga H, Whelan SL, eds. Cancer in Africa: epidemiology and prevention. Lyon: IARC, 2003.
2. Parkin DM, Whelan SL, Ferlay J, Thomas DB, Teppo L, eds. Cancer incidence in five continents. vol. 8. Lyon: IARC, 2002.
3. Chaouki N, Bosch FX, Muñoz N, Meijer CJ, El Gueddari B, El Ghazi A, Deacon J, Castellsagué X, Walboomers JM. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998;75:546-54.
4. Amrani M, Lalaoui K, El Mzibri M, Lazo P, Belabbas MA. Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447 swabs). J Clin Virol 2003;27:286-95.
5. Hassen E, Chaieb A, Letaief M, Khairi H, Zakhama A, Remadi S, Chouchane L. Cervical human papillomavirus infection in Tunisian women. Infection 2003;31:143-8.
6. Muñoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 2002;359:1093-101.
7. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
8. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000;87:221-7.
9. Jacobs MV, Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995;33:901-5.
10. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
11. IARC. Monographs on the evaluation of carcinogenic risks to humans. Human Papillomaviruses. Vol. 64. Lyon: IARC Press, 1995.
12. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-7.
13. Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, Muñoz N, Meijer CJ, Herrero R. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer 2003;107:127-33.
14. de Sanjosé S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz N, Catala I, Meijer CJ, Snijders PJ, Herrero R, Bosch FX. Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 2003;30:788-93.
15. Anh PT, Hieu NT, Herrero R, Vaccarella S, Smith JS, Thuy NT, Nga NH, Duc NB, Ashley R, Snijders PJ, Meijer CJ, Muñoz N, et al. Human papillomavirus infection among women in south and north Vietnam. Int J Cancer 2003;104:213-20.
16. Thomas JO, Herrero R, Omigbodun AA. Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Muñoz N, Snijders PJ, Meijer CJ, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004;90:638-45.
17. Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, Meijer CJ, Arslan A, Muñoz N. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002;87:324-33.
18. Lalaoui K, El Mzibri M, Amrani M, Belabbas MA, Lazo PA. Human papillomavirus DNA in cervical lesions from Morocco and its implications for cancer control. Clin Microbiol Infect 2003;9:144-8.
19. Castellsagué X, Menendez C, Loscertales MP, Kornegay JR, Dos SF, Gomez-Olive FX, Lloveras B, Abarca N, Vaz N, Barreto A, Bosch FX, Alonso P. Human papillomavirus genotypes in rural Mozambique. Lancet 2001;358:1429-30.
20. Bayo S, Bosch FX, de Sanjosé S, Muñoz N, Combita AL, Coursaget P, Diaz M, Dolo A, van den Brule AJ, Meijer CJ. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 2002;31:202-9.